KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
Cited by 292
Related Papers
Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
|Scientific Reports|2016|201
Delayed Remote Ischemic Preconditioning ConfersRenoprotection against Septic Acute Kidney Injury via Exosomal miR-21
|Theranostics|2019|193
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
|ESMO Open|2024|141
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival
|Oncotarget|2015|93
MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer
|Cancer Research|2016|66